Hmcn2 Activators
HMCN2 Activators encompass a series of chemical compounds that indirectly amplify the functional activity of HMCN2 through various signaling pathways associated with cell adhesion and extracellular matrix organization. Forskolin and 8-Br-cAMP, by elevating intracellular cAMP levels, indirectly promote HMCN2's role in matrix assembly through PKA activation, which phosphorylates targets that can affect cell-matrix interactions. Similarly, Sphingosine-1-phosphate engages S1P receptors, influencing cytoskeletal dynamics and potentially upregulating HMCN2 activity in extracellular matrix remodeling. Epigallocatechin gallate and Staurosporine act on multiple kinase pathways, modifying cell-matrix signaling and thereby indirectly enhancing HMCN2's structural contributions to the matrix. Phorbol 12-myristate 13-acetate, as a PKC activator, and the PI3K inhibitors LY294002 and Wortmannin, both modulate key pathways that could lead to the enhancement of HMCN2 in maintaining matrix architecture and facilitating cell adhesion.
The cellular impact of HMCN2 is further influenced by compounds that affect intracellular calcium levels and MAPK signaling, with Thapsigargin and A23187 raising calcium levels to activate pathways that may bolster HMCN2's extracellular matrix functions. U0126 and SB203580, by inhibiting MEK1/2 and p38 MAPK respectively, can alter cellular responses that indirectly support the enhancement of HMCN2 in matrix organization. These activators, through their unique and specific effects on cellular signaling, provide a multifaceted approach to upregulating the functional activity of HMCN2, focusing on its integral role in cell adhesion and the extracellular matrix, without the need to directly increase its expression or activation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC). PKC activation can influence cytoskeletal organization and cell-matrix interactions, which may indirectly upregulate HMCN2 activity due to its role in the extracellular matrix and cell adhesion. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol that acts as an antioxidant and has multiple effects on cellular signaling, including kinase inhibition. By modulating kinase activity, it could enhance HMCN2's function in matrix organization by altering signaling pathways involved in cell-matrix interactions. | ||||||
8-Bromoadenosine 3′,5′-cyclic monophosphate | 23583-48-4 | sc-217493B sc-217493 sc-217493A sc-217493C sc-217493D | 25 mg 50 mg 100 mg 250 mg 500 mg | $108.00 $169.00 $295.00 $561.00 $835.00 | 2 | |
8-Br-cAMP is a cAMP analog that activates PKA. Activation of PKA may influence cell adhesion and matrix assembly processes, potentially enhancing the structural role of HMCN2 in the extracellular matrix. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates S1P receptors, leading to modulation of cytoskeletal dynamics and cell adhesion. This could indirectly upregulate HMCN2 activity by influencing the extracellular matrix remodeling. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor that can modulate downstream AKT signaling. By influencing AKT activity, it may lead to altered cellular dynamics and matrix interactions, indirectly enhancing HMCN2 function. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is another PI3K inhibitor, which similarly to LY294002, can affect AKT signaling and thereby indirectly enhance HMCN2's role in matrix organization and cell adhesion. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), leading to increased intracellular calcium. Elevated calcium can activate calcium-dependent signaling pathways, which may enhance HMCN2's activity related to matrix organization. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is an ionophore that increases intracellular calcium levels. This increase can activate calcium-dependent pathways, potentially enhancing HMCN2 function in the extracellular matrix and cell adhesion. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is a MEK inhibitor that can influence the MAPK/ERK pathway. Altered MAPK signaling may have downstream effects on cell-matrix interactions, potentially enhancing the role of HMCN2 in matrix organization. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 is a p38 MAPK inhibitor that can modify cellular responses to stress and inflammation, potentially altering the extracellular matrix and enhancing the role of HMCN2 in this context. | ||||||